Global Roxadustat Market Growth 2025-2031

Publication ID:

LPI04254947

Publication Date:

April 23, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Roxadustat market size is predicted to grow from US$ 14200 million in 2025 to US$ 19930 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Used to treat anemia due to chronic kidney disease (CKD) in patients undergoing dialysis treatment
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淩oxadustat Industry Forecast鈥� looks at past sales and reviews total world Roxadustat sales in 2024, providing a comprehensive analysis by region and market sector of projected Roxadustat sales for 2025 through 2031. With Roxadustat sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Roxadustat industry.
This Insight Report provides a comprehensive analysis of the global Roxadustat landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Roxadustat portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Roxadustat market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Roxadustat and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Roxadustat.
This report presents a comprehensive overview, market shares, and growth opportunities of Roxadustat market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
20mg
50mg
Segmentation by Application:
Pharmacy
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Fibro Gen
AstraZeneca
Astellas Pharma Inc.
Salubris
Key Questions Addressed in this Report
What is the 10-year outlook for the global Roxadustat market?
What factors are driving Roxadustat market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Roxadustat market opportunities vary by end market size?
How does Roxadustat break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Roxadustat Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Roxadustat by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Roxadustat by Country/Region, 2020, 2024 & 2031
2.2 Roxadustat Segment by Type
2.2.1 20mg
2.2.2 50mg
2.3 Roxadustat Sales by Type
2.3.1 Global Roxadustat Sales Market Share by Type (2020-2025)
2.3.2 Global Roxadustat Revenue and Market Share by Type (2020-2025)
2.3.3 Global Roxadustat Sale Price by Type (2020-2025)
2.4 Roxadustat Segment by Application
2.4.1 Pharmacy
2.4.2 Hospital
2.5 Roxadustat Sales by Application
2.5.1 Global Roxadustat Sale Market Share by Application (2020-2025)
2.5.2 Global Roxadustat Revenue and Market Share by Application (2020-2025)
2.5.3 Global Roxadustat Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Roxadustat Breakdown Data by Company
3.1.1 Global Roxadustat Annual Sales by Company (2020-2025)
3.1.2 Global Roxadustat Sales Market Share by Company (2020-2025)
3.2 Global Roxadustat Annual Revenue by Company (2020-2025)
3.2.1 Global Roxadustat Revenue by Company (2020-2025)
3.2.2 Global Roxadustat Revenue Market Share by Company (2020-2025)
3.3 Global Roxadustat Sale Price by Company
3.4 Key Manufacturers Roxadustat Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Roxadustat Product Location Distribution
3.4.2 Players Roxadustat Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Roxadustat by Geographic Region
4.1 World Historic Roxadustat Market Size by Geographic Region (2020-2025)
4.1.1 Global Roxadustat Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Roxadustat Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Roxadustat Market Size by Country/Region (2020-2025)
4.2.1 Global Roxadustat Annual Sales by Country/Region (2020-2025)
4.2.2 Global Roxadustat Annual Revenue by Country/Region (2020-2025)
4.3 Americas Roxadustat Sales Growth
4.4 APAC Roxadustat Sales Growth
4.5 Europe Roxadustat Sales Growth
4.6 Middle East & Africa Roxadustat Sales Growth
5 Americas
5.1 Americas Roxadustat Sales by Country
5.1.1 Americas Roxadustat Sales by Country (2020-2025)
5.1.2 Americas Roxadustat Revenue by Country (2020-2025)
5.2 Americas Roxadustat Sales by Type (2020-2025)
5.3 Americas Roxadustat Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Roxadustat Sales by Region
6.1.1 APAC Roxadustat Sales by Region (2020-2025)
6.1.2 APAC Roxadustat Revenue by Region (2020-2025)
6.2 APAC Roxadustat Sales by Type (2020-2025)
6.3 APAC Roxadustat Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Roxadustat by Country
7.1.1 Europe Roxadustat Sales by Country (2020-2025)
7.1.2 Europe Roxadustat Revenue by Country (2020-2025)
7.2 Europe Roxadustat Sales by Type (2020-2025)
7.3 Europe Roxadustat Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Roxadustat by Country
8.1.1 Middle East & Africa Roxadustat Sales by Country (2020-2025)
8.1.2 Middle East & Africa Roxadustat Revenue by Country (2020-2025)
8.2 Middle East & Africa Roxadustat Sales by Type (2020-2025)
8.3 Middle East & Africa Roxadustat Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Roxadustat
10.3 Manufacturing Process Analysis of Roxadustat
10.4 Industry Chain Structure of Roxadustat
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Roxadustat Distributors
11.3 Roxadustat Customer
12 World Forecast Review for Roxadustat by Geographic Region
12.1 Global Roxadustat Market Size Forecast by Region
12.1.1 Global Roxadustat Forecast by Region (2026-2031)
12.1.2 Global Roxadustat Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Roxadustat Forecast by Type (2026-2031)
12.7 Global Roxadustat Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Fibro Gen
13.1.1 Fibro Gen Company Information
13.1.2 Fibro Gen Roxadustat Product Portfolios and Specifications
13.1.3 Fibro Gen Roxadustat Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Fibro Gen Main Business Overview
13.1.5 Fibro Gen Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Roxadustat Product Portfolios and Specifications
13.2.3 AstraZeneca Roxadustat Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Astellas Pharma Inc.
13.3.1 Astellas Pharma Inc. Company Information
13.3.2 Astellas Pharma Inc. Roxadustat Product Portfolios and Specifications
13.3.3 Astellas Pharma Inc. Roxadustat Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Astellas Pharma Inc. Main Business Overview
13.3.5 Astellas Pharma Inc. Latest Developments
13.4 Salubris
13.4.1 Salubris Company Information
13.4.2 Salubris Roxadustat Product Portfolios and Specifications
13.4.3 Salubris Roxadustat Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Salubris Main Business Overview
13.4.5 Salubris Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂